TREE NEWS update: Injective CEO Eric Chen said US spot INJ ETFs could launch sooner than 2027. Two ETF applications tied to INJ are currently pending: the 21Shares Injective ETF and the Canary Staked INJ ETF.
Injective CEO Eric Chen Expects US INJ ETFs to Launch Before 2027
AI take
The signal here is less the timeline than the source: a project founder publicly framing US spot listing as a matter of when, not if, while two applications sit pending. That matters for INJ holders and the broader altcoin ETF pipeline, since founder commentary can shape expectations before regulators act. The open question is whether those pending applications actually clear, and whether staked-product structures like Canary's draw the same scrutiny as plain spot filings.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
11m ago
China’s Central Bank to Conduct 1-Year Swap Facility for Securities, Funds, Insurers on Nov 3
48m ago
Crypto Prediction Markets Give Democrats 72% Chance of Sweeping Congress
50m ago
SK Hynix and Samsung Shares Rise; Gate Stock Futures Open Interest Ranks Second Globally
53m ago
Pendle: PendleLoop ETH long costs 70-90% less than Hyperliquid perps
1h ago
Huobi HTX Lists Perpetual Contracts for EWZS, OXY, SMR, NU and MPWR
1h ago
OKX Predicts Apple Beat at 71%, but First-Day Gain at 47%